Top Markets
Coin of the day
Acepodia, Inc. Acepodia, Inc.

Acepodia, Inc.

6976
Rang in Aktien #17936
Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering... Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering cell-based treatments. The company utilizes its distinctive Antibody Cell Conjugation (ACC) platform technology to innovate therapeutic approaches and address critical unmet needs in oncology. Through this proprietary method, Acepodia engineers novel ACE therapies by precisely attaching tumor-specific antibodies to its specialized immune cells, such as gamma delta 2 T cells. Established in 2017, the company's corporate headquarters are situated in Grand Cayman, Cayman Islands.
Aktienkurs
$0.38317829
Marktkapitalisierung
$222.43M
Veränderung (1 Tag)
1.26%
Veränderung (1 Jahr)
-26.39%
Land
KY
Handel Acepodia, Inc. (6976)

Kategorie

Kursverlauf für Acepodia, Inc. (6976)
Höchster Schlusskurs: $0.38 am 2026-09-01

Niedrigster Schlusskurs: $1.15 am 2023-08-01
Kursverlauf der Aktie von Acepodia, Inc. von 2023 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -8.02%
2025 -10.36%
2024 -47.41%
2023 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$122.68 -9.23%
AU
$757.71 6.76%
CH